feed,title,long_url,short_url
RS,Comparison of IMC-2 alone and IMC-2 and PaxlovidÂ® shows substantial short and long-term efficacy in reducing symptoms of Long COVID with combination therapy: a case series,https://www.researchsquare.com/article/rs-7500476/latest,
